{"anticipatedPostingDate":"2028-07","denomUnitsSelected":"Participants","description":"MRD is defined as the percentage of participants achieving CR who are MRD-negative at multiple intervals after end of induction. MRD negativity: \\<=0.01% BCR-ABL1/ABL1, or undetectable BCR-ABL1 transcripts in cDNA with \\>=10,000 ABL1 transcripts. Relapse from CR: Reappearance of blasts in the blood or BM (\\>=5%) or in any extramedullary site after a CR.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 3 to 6 years","title":"Percentage of MRD-Negative CR","type":"SECONDARY"}